v3.26.1
OTHER FINANCIAL INFORMATION - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Clinical trials $ 4,397 $ 10,794
Compensation-related 3,851 7,450
Clinical drug substance and product manufacturing 2,064 5,542
Professional fees 1,920 447
Interest expense 1,451 857
Other outside research and development 118 111
Other 1,972 328
Accrued expenses $ 15,773 $ 25,529